These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 32425638)

  • 1. Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - Achieving global consensus and visibility for cellular host-directed therapies.
    Zumla A; Wang FS; Ippolito G; Petrosillo N; Agrati C; Azhar EI; Chang C; El-Kafrawy SA; Osman M; Zitvogel L; Galle PR; Locatelli F; Gorman E; Cordon-Cardo C; O'Kane C; McAuley D; Maeurer M
    Int J Infect Dis; 2020 Jul; 96():431-439. PubMed ID: 32425638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
    Atluri S; Manchikanti L; Hirsch JA
    Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.
    Rogers CJ; Harman RJ; Bunnell BA; Schreiber MA; Xiang C; Wang FS; Santidrian AF; Minev BR
    J Transl Med; 2020 May; 18(1):203. PubMed ID: 32423449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial.
    Meng F; Xu R; Wang S; Xu Z; Zhang C; Li Y; Yang T; Shi L; Fu J; Jiang T; Huang L; Zhao P; Yuan X; Fan X; Zhang JY; Song J; Zhang D; Jiao Y; Liu L; Zhou C; Maeurer M; Zumla A; Shi M; Wang FS
    Signal Transduct Target Ther; 2020 Aug; 5(1):172. PubMed ID: 32855385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019.
    Canham MA; Campbell JDM; Mountford JC
    J Transl Med; 2020 Sep; 18(1):359. PubMed ID: 32958009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stem Cell Therapy for COVID-19: Present or Future.
    Golchin A; Seyedjafari E; Ardeshirylajimi A
    Stem Cell Rev Rep; 2020 Jun; 16(3):427-433. PubMed ID: 32281052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
    Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B
    BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
    Al-Khawaga S; Abdelalim EM
    Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment.
    Saldanha-Araujo F; Melgaço Garcez E; Silva-Carvalho AE; Carvalho JL
    Front Immunol; 2020; 11():1563. PubMed ID: 32719683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19: The Immune Responses and Clinical Therapy Candidates.
    Zhand S; Saghaeian Jazi M; Mohammadi S; Tarighati Rasekhi R; Rostamian G; Kalani MR; Rostamian A; George J; Douglas MW
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32756480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Effectiveness of Intravascular Mesenchymal Stem Cells to Treat Organ Failure and Possible Application in COVID-19 Complications.
    Atluri S; Manocha V; Boddu N; Bhati S; Syed Z; Diwan S; Manchikanti L
    Pain Physician; 2020 Aug; 23(4S):S391-S420. PubMed ID: 32942796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy.
    Moll G; Drzeniek N; Kamhieh-Milz J; Geissler S; Volk HD; Reinke P
    Front Immunol; 2020; 11():1091. PubMed ID: 32574263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells as a potential therapy for COVID-19.
    Liu S; Peng D; Qiu H; Yang K; Fu Z; Zou L
    Stem Cell Res Ther; 2020 May; 11(1):169. PubMed ID: 32366290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19.
    Li C; Zhao H; Wang B
    Drug Des Devel Ther; 2020; 14():3995-4001. PubMed ID: 33061304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential.
    Khoury M; Rocco PRM; Phinney DG; Krampera M; Martin I; Viswanathan S; Nolta JA; LeBlanc K; Galipeau J; Weiss DJ
    Cytotherapy; 2020 Nov; 22(11):602-605. PubMed ID: 32933835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence-FAST Evidence.
    Liao G; Zheng K; Lalu MM; Fergusson DA; Allan DS
    Transfus Med Rev; 2020 Jul; 34(3):165-171. PubMed ID: 32684483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can mesenchymal stem cell therapy be the interim management of COVID-19?
    Bamba C; Singh SP; Choudhury S
    Drug Discov Ther; 2020 Jul; 14(3):139-142. PubMed ID: 32554953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review.
    Razmi M; Hashemi F; Gheytanchi E; Dehghan Manshadi M; Ghods R; Madjd Z
    Int Immunopharmacol; 2020 Nov; 88():106942. PubMed ID: 32896750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019.
    Zayed M; Iohara K
    Cell Transplant; 2020; 29():963689720952089. PubMed ID: 32830527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.